iMODE interaktif mizaç belirleme motoru
Bu tez size mi ait?
Bu kayıt toplu arşivden geldi. Sizinse profilinize bağlayın.
Özet (EN)
Applications change their mood from time to time. A memory-intensive application does not need to be always memory-intensive from its first instruction to its last. Similarly, it is highly usual that a computation-intensive application generates heavy memory traffic at certain points of its entire run. Meanwhile, processors are designed to have a fixed resource configuration, which is expected to serve all kinds of applications with all kinds of program phases. In this study, we propose a new processor, which tracks down instant mood changes of running applications and applies immediate processor mode changes between in-order and out-of-order modes for either saving power or keeping up with the high-performance demands of applications. In our experiments, we observe that the proposed processor can really track the mood changes of applications, accurately, and achieves 17 percent power savings with only less than 1 percent of performance drop, on the average across all simulated benchmarks.
Yazar
Muhammed Emin Savaş
Bu Yayına Nasıl Atıf Yapılır
Muhammed Emin Savaş (Master Thesis). iMODE interaktif mizaç belirleme motoru, 2019, Yeditepe University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Yeditepe University tezlerinden daha fazlası
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)